KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precigen (PGEN) Capital Expenditures (2016 - 2025)

Precigen (PGEN) has disclosed Capital Expenditures for 12 consecutive years, with $389000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Capital Expenditures fell 55.9% to $389000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $3.0 million, a 63.88% decrease, with the full-year FY2024 number at $8.6 million, up 458.85% from a year prior.
  • Capital Expenditures was $389000.0 for Q3 2025 at Precigen, down from $966000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $7.1 million in Q4 2021 to a low of -$3.1 million in Q3 2022.
  • A 5-year average of $1.0 million and a median of $517000.0 in 2023 define the central range for Capital Expenditures.
  • Biggest YoY gain for Capital Expenditures was 5740.74% in 2022; the steepest drop was 3231.18% in 2022.
  • Precigen's Capital Expenditures stood at $7.1 million in 2021, then crashed by 102.23% to -$159000.0 in 2022, then surged by 580.5% to $764000.0 in 2023, then skyrocketed by 34.55% to $1.0 million in 2024, then tumbled by 62.16% to $389000.0 in 2025.
  • Per Business Quant, the three most recent readings for PGEN's Capital Expenditures are $389000.0 (Q3 2025), $966000.0 (Q2 2025), and $622000.0 (Q1 2025).